Orthopedic diseases encompass a wide range of conditions affecting the musculoskeletal system, such as fractures, sprains, strains, osteoarthritis, rheumatoid arthritis, and osteoporosis. For instance, according to the WHO data, in 2020, over 18 million people globally were suffering from rheumatoid arthritis and is anticipated to increase in the future. Orthopedic splints help alleviate pain and aid in joint stabilization among patients suffering from rheumatoid arthritis and other orthopedic ailments. Sedentary lifestyles, coupled with the rising prevalence of obesity, contribute to the development of orthopedic diseases.
Additionally, technological advancements in orthopedic splints, such as the use of lightweight and durable materials, adjustable designs, and ergonomic features, have improved patient comfort and treatment outcomes. There is an increasing awareness of orthopedic diseases and their impact on individuals' quality of life. This awareness has led to more individuals seeking medical attention, leading to improved diagnosis rates. As orthopedic diseases are diagnosed earlier and more accurately, the need for orthopedic splints as a treatment option increases. The increasing prevalence of orthopedic diseases, driven by factors such as an aging population, sedentary lifestyles, and sports injuries, creates a favourable market landscape for orthopedic splints.